An Integrated Approach to Clinical Genetics Research
9 Apr 2014
Oxford Gene Technology (OGT), The Molecular Genetics Company, has produced a new whitepaper titled ‘Comprehensive genomic analysis – complementing sequencing with high-resolution CNV detection’. The free, downloadable whitepaper provides researchers with an opportunity to explore the latest strategies in the genomic characterization of complex disorders, and to discover how, when used alongside sequencing, microarrays play a vital role in delivering accurate detection of point mutations and single exon copy number aberrations.
The new whitepaper explains how utilizing a range of available tools builds a more complete picture of inherently complex genetic disorders, providing the insights necessary to drive novel discoveries and research into potential therapeutic strategies. At the forefront of this approach is Professor Madhuri Hegde, Professor of Human Genetics at Emory Genetics Laboratory (EGL, Atlanta, USA), whose success in applying such an integrated strategy is also explored.
The paper highlights that while targeted DNA sequencing presents a valuable approach for genomic analysis, it is unable to detect copy number variations (CNV) with certainty. In contrast, comparative genomic hybridization arrays (aCGH) are the gold-standard for CNV detection and the 60-mer oligonucleotide probes utilized by OGT’s aCGH platform have been shown to deliver superior CNV detection compared with alternative platforms.
In collaboration with experts at EGL, OGT has designed a range of molecular arrays that are the ideal complement to DNA sequencing, providing a particularly powerful tool for investigating the variety of aberrations underlying genetic disorders. The resulting CytoSure Molecular Array portfolio enables detection of CNV in genes associated with over 20 genetic disorders including cardiovascular, intellectual disability, inherited cancers and neuromuscular disorders, with the additional option to create custom arrays.
Also available to watch online is a recording of OGT’s recent American College of Medical Genetics (ACMG) workshop, where Professor Hegde discusses the design and application of the new CytoSure Medical Exome Array, which covers over 4600 hand-curated genes for accurate detection of medically-relevant CNV.
Related Products
Request Quote for All Products
CytoSure™ Molecular Arrays
Oxford Gene Technology LtdReliable detection of copy number changes for research into a range of genetic disorders. CytoSure Molecular Arrays are designed to accurately identify small intragenic copy number variations (CNVs) in genes associated with a variety of disorders. The content for each array has been designed and optimised in collaboration with leading molecular genetics experts at Emory University. In addition to pre-designed catalogue arrays, you can also utilise our extensive array design expertise to produce custom arrays matching your precise specifications.CytoSure™ Molecular Arrays Features: Accurate detection of copy number variation — a perfect complement to sequencing analysis Array content fully optimised and research-validated by Emory University Flexible array content and formats — create the ideal array for your needs Cost-effective processing — multiple molecular disorders can be included in a single array Easy data interpretation using optimised protocols and industry-leading CytoSure Interpret Software
Genefficiency™ RNA-Seq Service
Oxford Gene Technology LtdA high-quality RNA sequencing service designed to deliver cost-effective and rapid access to meaningful transcriptomics results. The Genefficiency™ RNA-Seq Service from OGT provides a new level of assay customisation to ensure each experiment is fully optimised to suit your specific study objectives. At OGT we understand the time and effort it takes to generate good quality RNA and how precious your samples are. Whether you are looking for array equivalent output on known specific genes, quantification of novel or known alternative splicing variants for your gene of interest or the detection of a rare transcript, OGT will guide you every step of the way.Our expert team will provide advice on the correct combination of starting material, sequencing depth and the level of bioinformatics required to reach your goals — delivering successful and cost-effective results.Genefficiency™ RNA-Seq Service Features: Comprehensive interactive report — delivering rapid access to your results Full advice and consultation — saving time and money Enhance your existing gene expression studies — with nucleotide-level data Dedication to quality — providing confidence in your results
Genefficiency™ Targeted Sequencing Services
Oxford Gene Technology LtdOGT can help you get straight to the variant of interest with whole exome or custom targeted sequencing services. Genefficiency™ targeted sequencing services are designed to be different, leading you all the way from project conception to high-quality results. Our expert and comprehensive project design and analysis solutions — incorporating Agilent SureSelect, Illumina HiSeq 2000 and OGT-developed software platforms — are tailored to your specific needs allowing you to discover, not just sequence. Results are delivered in an interactive report, allowing rapid identification of meaningful variation, without the requirement for in-house bioinformatics resource.Genefficiency™ Targeted Sequencing Services Features: Expert whole exome or custom capture and enrichment Effective project and capture probe design Cost-efficient barcoding and sequencing Comprehensive interactive data analysis report, allowing rapid filtering and prioritisation of data A dedication to quality from sample preparation to data interpretation